Chronic Myeloid Leukemia Coverage from Every Angle

Kendra Sweet, MD, on CML and COVID-19: Which Patients Are at High Risk for Coronavirus Complications?

Posted: Tuesday, May 12, 2020

Kendra Sweet, MD, of Moffitt Cancer Center, talks about the risks of coronavirus complications among patients with chronic myeloid leukemia whose cancer is well controlled with ongoing TKI therapy or who discontinued treatment and remain in remission.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.